These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 31805829)

  • 1. The incidence and prevalence of hospital-acquired (carbapenem-resistant)
    Ayobami O; Willrich N; Harder T; Okeke IN; Eckmanns T; Markwart R
    Emerg Microbes Infect; 2019; 8(1):1747-1759. PubMed ID: 31805829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening and early precautions for carbapenem-resistant
    Yamamoto N; Hamaguchi S; Akeda Y; Santanirand P; Chaihongsa N; Sirichot S; Chiaranaicharoen S; Hagiya H; Yamamoto K; Kerdsin A; Okada K; Yoshida H; Hamada S; Oishi K; Malathum K; Tomono K
    Antimicrob Resist Infect Control; 2019; 8():110. PubMed ID: 31297191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 7. Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA).
    Rao J; Susanti D; Childress JC; Mitkos MC; Brima JK; Baffoe-Bonnie AW; Pearce SN; Grgurich D; Fernandez-Cotarelo MJ; Kerkering TM; Mukhopadhyay B
    J Glob Antimicrob Resist; 2018 Mar; 12():79-87. PubMed ID: 28899807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii.
    Teerawattanapong N; Panich P; Kulpokin D; Na Ranong S; Kongpakwattana K; Saksinanon A; Goh BH; Lee LH; Apisarnthanarak A; Chaiyakunapruk N
    Infect Control Hosp Epidemiol; 2018 May; 39(5):525-533. PubMed ID: 29580299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 13. Environmental colonization and onward clonal transmission of carbapenem-resistant
    Ng DHL; Marimuthu K; Lee JJ; Khong WX; Ng OT; Zhang W; Poh BF; Rao P; Raj MDR; Ang B; De PP
    Antimicrob Resist Infect Control; 2018; 7():51. PubMed ID: 29644052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant
    Zhang Y; Xu G; Miao F; Huang W; Wang H; Wang X
    Front Public Health; 2023; 11():1282413. PubMed ID: 38098829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antibiotic exposure on antibiotic-resistant Acinetobacter baumannii isolation in intensive care unit patients: a systematic review and meta-analysis.
    De Blasiis MR; Sciurti A; Baccolini V; Isonne C; Ceparano M; Iera J; De Vito C; Marzuillo C; Villari P; Migliara G
    J Hosp Infect; 2024 Jan; 143():123-139. PubMed ID: 37972711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and genetic characteristics of clinical carbapenem-resistant
    Liu C; Chen K; Wu Y; Huang L; Fang Y; Lu J; Zeng Y; Xie M; Chan EWC; Chen S; Zhang R
    Emerg Microbes Infect; 2022 Dec; 11(1):1730-1741. PubMed ID: 35730377
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
    J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
    Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A
    J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.